Content Type: Research Publications

Revisiting the National Institutes of Health Fair Pricing Condition: Promoting the Affordability of Drugs Developed with Government Support

March 16, 2026

Reprioritizing Research Activity for the Post‐Antibiotic Era: Ethical, Legal, and Social Considerations

March 16, 2026

Evolution of Insulin Patents and Market Exclusivities in the USA

March 16, 2026

New Treatments for Migraine: Therapeutic Ratings and Comparative Coverage in the US, Canada, and Europe

March 16, 2026

Review Times and Adverse Events for Cardiovascular Devices

March 16, 2026

Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail The Last Barrier?

March 16, 2026

Benefits, Limitations, and Value of Abuse-Deterrent Opioids

March 16, 2026

Does Helicobacter Pylori Eradication Therapy to Prevent Gastric Cancer Increase All‐Cause Mortality?

March 16, 2026

Distributions of Industry Payments to Massachusetts Physicians

March 16, 2026

Off-Label Drug Use and Promotion: Balancing Public Health Goals and Commercial Speech

March 16, 2026

US Taxpayers Heavily Funded the Discovery of COVID‐19 Vaccines

March 16, 2026

Origins and Ownership of Remdesivir: Implications for Pricing

March 15, 2026